Institutional members access full text with Ovid®

Share this article on:

Improvements in Symptoms of Attention-Deficit/Hyperactivity Disorder in School-Aged Children with Lisdexamfetamine Dimesylate [LDX; NRP104] and Mixed Amphetamine Salts Extended-Release vs. Placebo

Biederman, Joseph1; Boellner, Samuel W.2; Childress, Ann3; Lopez, Frank A.4; Krishnan, Suma5; Mandler, Hilary6

Journal of Developmental & Behavioral Pediatrics: October 2006 - Volume 27 - Issue 5 - p 442
Abstracts: Abstracts of Papers Accepted for Presentation at the Annual Meeting of the Society for Developmental and Behavioral Pediatrics: Poster Session, Sunday, September 17, 2006, 6:00 p.m. - 7:00 p.m.: Abstract # 43

1Clinical and Research Program in Pediatric Psychopharmacology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; 2Clinical Study Centers, Little Rock, AR; 3Center for Psychiatry and Behavioral Medicine, Las Vegas, NV; 4Children's Developmental Center, Maitland, FL; 5New River Pharmaceuticals Inc, Blacksburg, VA; 6Shire Development Inc, Wayne, PA.

© 2006 Lippincott Williams & Wilkins, Inc.